Alqahtani A, Nguyen L T, Flageole H, Shaw K, Laberge J M
The Montreal Children's Hospital, Department of Surgery, McGill University, Quebec, Canada.
J Pediatr Surg. 1999 Jul;34(7):1164-8. doi: 10.1016/s0022-3468(99)90590-0.
BACKGROUND/PURPOSE: The management of lymphangioma in children is challenging because complete resection is difficult to achieve in some cases, and recurrences are common. The authors reviewed their experience to assess the risk factors for recurrence and the role of nonoperative treatment.
A retrospective study over a period of 25 years was carried out. One hundred eighty-six patients with 191 lesions (five patients with de novo lesions in different sites) were treated. There were 98 boys and 88 girls. The average age at diagnosis was 3.3 years (range, fetal life to 17 years) and the average size 8 cm in diameter. Histocytological confirmation was obtained in all patients. The involved sites were head and neck, 89 patients (48%); trunk and extremities, 78 patients (42%); internal or visceral locations (eg, abdominal and thorax), 19 patients (10%). The treatment consisted of macroscopically complete excision in 145 patients (150 lesions, of which five were recurrences in different sites), partial excision in 10 patients, aspiration in five patients, laser excision in 10 patients, biopsy only in four patients, drainage and biopsy in two patients, and injection of sclerosing agents in 10 patients.
There were 54 recurrences; 44 underwent excision (five of them more than once), and five regressed spontaneously on follow-up. Five other recurrences were stable and not progressing. Recurrences, (defined as clinically obvious disease), were found to be 100% after aspiration, 100% after injection, 40% after incomplete excision, 40% after laser excision, and 17% after macroscopically complete excision. The recurrence rate in the last group was the highest in the head (33%), the least in the internal locations (0%), and intermediate for the cervical location (13%). There were no significant differences, in terms of outcome, between those who had their surgery immediately at the time of diagnosis (n = 101) and those who had delayed surgery (n = 85).
There were fewer recurrences after macroscopically complete excision. Aspiration and injection had the highest recurrence rate. Risk factors for recurrence included location, size, and complexity of lesions. A period of observation may be useful for infants to facilitate complete excision. In the present series, spontaneous regression was infrequent and was seen more often with recurrent lesions.
背景/目的:儿童淋巴管瘤的治疗具有挑战性,因为在某些情况下难以实现完全切除,且复发很常见。作者回顾了他们的经验,以评估复发的危险因素和非手术治疗的作用。
进行了一项为期25年的回顾性研究。共治疗了186例患者的191处病变(5例患者在不同部位有新发病变)。其中男孩98例,女孩88例。诊断时的平均年龄为3.3岁(范围为胎儿期至17岁),平均大小为直径8厘米。所有患者均获得了组织细胞学确诊。受累部位包括头颈部,89例患者(48%);躯干和四肢,78例患者(42%);内部或内脏部位(如腹部和胸部),19例患者(10%)。治疗方法包括145例患者(150处病变,其中5处为不同部位的复发)进行肉眼下完全切除,10例患者进行部分切除,5例患者进行抽吸,10例患者进行激光切除,4例患者仅进行活检,2例患者进行引流和活检,10例患者注射硬化剂。
共有54例复发;44例接受了切除(其中5例不止一次),5例在随访中自发消退。另外5例复发情况稳定且无进展。复发(定义为临床上明显的疾病)在抽吸后为100%,注射后为100%,不完全切除后为40%,激光切除后为40%,肉眼下完全切除后为17%。最后一组的复发率在头部最高(33%),在内脏部位最低(0%),在颈部为中等(13%)。在诊断时立即进行手术的患者(n = 101)和延迟手术的患者(n = 85)之间,就结果而言没有显著差异。
肉眼下完全切除后复发较少。抽吸和注射的复发率最高。复发的危险因素包括病变的部位、大小和复杂性。对于婴儿,观察一段时间可能有助于实现完全切除。在本系列中,自发消退很少见,且在复发病变中更常见。